During the past decade, Gastro Florida conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 17 clinical trials were completed, i.e. on average, 36.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 17 clinical trials were completed. i.e. 81% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastro Florida" #1 sponsor was "Celgene" with 7 trials, followed by "Pfizer" with 5 trials sponsored, "Shire" with 5 trials sponsored, "Target PharmaSolutions, Inc." with 5 trials sponsored and "Hoffmann-La Roche" with 5 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastro Florida" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Gastro Florida" are "Ulcerative Colitis" (14 trials), "Crohn's Disease" (10 trials), "Crohn Disease" (8 trials), "Colitis, Ulcerative" (4 trials) and "Clostridium Difficile Infection Recurrence" (2 trials). Many other conditions were trialed in "Gastro Florida" in a lesser frequency.

Most popular intervention types in "Gastro Florida" are "Drug" (39 trials), "Other" (10 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Etrasimod" (5 trials), "Etrolizumab" (4 trials), "Ontamalimab" (4 trials) and "Ozanimod" (4 trials). Other intervention names were less common.

The vast majority of trials in "Gastro Florida" are 47 trials for "All" genders.

Currently, there are NaN active trials in "Gastro Florida". undefined are not yet recruiting, 17 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Gastro Florida, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Gastro Florida, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".